The Equality Act (HR 15) amends federal civil rights laws to explicitly prohibit discrimination based on sexual orientation and gender identity in employment, housing, public accommodations, credit, and jury service. It expands existing protections under the Civil Rights Act of 1964 by adding sexual orientation and gender identity as protected characteristics under sex discrimination prohibitions. The bill clarifies that discrimination against LGBTQ people is a form of sex discrimination, consistent with the Supreme Court's Bostock decision, and adds specific definitions for gender identity and sexual orientation. This legislation directly affects businesses, employers, housing providers, financial institutions, and government entities that serve the public. The bill creates a more comprehensive legal framework to address discrimination that LGBTQ people face in multiple aspects of daily life.
HR 3063, the Rural Hospital Stabilization Act of 2025, provides federal grants to help financially struggling rural hospitals in remote areas (defined as at least 15 miles from the nearest hospital and 20 miles from urban areas). The bill authorizes up to $5 million per hospital over five years for facility repairs, equipment upgrades, and operational costs like non-leadership payroll and debt payments, while requiring hospitals to demonstrate how projects address financial needs and ensure continued community access. Grants must supplement - not replace - existing funding, and hospitals must submit sustainability plans. The $500 million total funding authorization covers fiscal years after 2025, with a report to Congress on program outcomes within 18 months.
This Senate resolution (SRES 106) expresses the U.S. Senate's support for International Women’s Day (March 8, 2025) and recognizes the importance of advancing women’s rights globally. It affirms that women’s empowerment is critical to achieving economic growth, sustainable peace, and security, citing statistics on gender-based violence, educational gaps, and underrepresentation in leadership. The resolution does not create new laws or policies but formally acknowledges the Senate’s commitment to addressing barriers women face, including violence, discrimination, and limited participation in decision-making. It specifically highlights challenges in conflict zones like Afghanistan and Ukraine, urging U.S. action to support women’s rights worldwide. As a non-binding resolution, it serves as a symbolic statement of support rather than a legislative change.
This resolution (SRES 98) condemns the Chinese government's implementation of Hong Kong's National Security Law and the Article 23 Ordinance, which the Senate states have undermined Hong Kong's autonomy, rule of law, and freedoms. It specifically urges accountability for actions like the sentencing of pro-democracy figures (including Jimmy Lai) and calls for Hong Kong authorities to drop related charges. The resolution also advocates for U.S. and international efforts to adjust Hong Kong's voting status at multilateral organizations, arguing that Hong Kong no longer maintains meaningful independence from mainland China. As a non-binding resolution, it does not enact new laws but formally expresses the Senate's position on these matters.
This Senate resolution (SRES 86) expresses the Senate's official position on a longstanding diplomatic issue. It clarifies that United Nations General Assembly Resolution 2758 (1971), which determined China's UN seat representation, does not endorse China's "One China Principle" (claiming Taiwan is part of China) or address Taiwan's political status. The resolution reaffirms the U.S. "One China Policy" does not accept China's sovereignty claim over Taiwan and opposes China's misuse of Resolution 2758 to isolate Taiwan from international organizations like the WHO or UN agencies. It specifically supports Taiwan's meaningful participation in international forums and opposes China's coercion of other nations to sever ties with Taiwan. The resolution is non-binding but aims to correct factual misrepresentations used to limit Taiwan's global engagement.
This bill requires most health insurance plans to cover diagnostic and supplemental breast examinations with no out-of-pocket costs (like deductibles or copays) for enrollees. It specifically covers medically necessary exams used to evaluate abnormalities (diagnostic) or for high-risk screening (supplemental), following national cancer guidelines. Insurance plans may still require prior authorization but cannot impose cost-sharing for these services. The rule applies to group and individual plans starting January 1, 2026, and does not override stricter state laws protecting coverage.
Break Up Suspicious Transactions of Fentanyl Act or the BUST FENTANYL Act This bill revives a requirement for the President to identify foreign opioid traffickers and extends opioid trafficking sanctions to new categories of foreign persons (individuals and entities) whose actions support such trafficking. Specifically, the bill revives through 2030 a requirement that the President annually submit a report to Congress identifying foreign opioid traffickers. (For those listed in the report, the President must select certain sanctions to impose on them, such as bans on loans, foreign exchange transactions, and property transactions.) The bill also specifies that such reports must prioritize the identification of Chinese nationals and entities involved in the shipment of fentanyl, fentanyl-related chemicals, and fentanyl manufacturing equipment to Mexico or any other country involved in the production of fentanyl trafficked to the United States. The bill extends such foreign opioid trafficker sanctions to additional categories of foreign persons, including those that have knowingly (1) engaged in significant activities or financial transactions that materially contributed to opioid trafficking; or (2) provided financial, material, or technological support for such activities or transactions. The bill also authorizes the President to impose these sanctions on foreign government entities, including government owned or controlled financial institutions, that are involved in activities that contribute to opioid trafficking. Additionally, the President may impose property-blocking sanctions on senior officials of these foreign government entities who knowingly facilitate such activities.
The MEGOBARI Act requires the U.S. Secretary of State to suspend the U.S.-Georgia Strategic Partnership Commission until Georgia demonstrates progress toward democratic reforms and advancing its EU/NATO aspirations. It authorizes sanctions - including visa bans and property blocks - against Georgian officials (including parliament members and senior government leaders) who obstruct Euro-Atlantic integration or engage in corruption undermining Georgia’s sovereignty. The bill mandates a U.S. strategy for Georgia relations within 90 days and a report on Russian intelligence influence in Georgia within 180 days. These measures directly target Georgian government officials and political actors, with sanctions applying to those deemed to block democratic progress or Georgia’s Euro-Atlantic path.
This bill requires most private health insurance plans to cover diagnostic and supplemental breast exams with no out-of-pocket costs (like deductibles or copays) for enrolled patients. It specifically covers exams used to evaluate abnormalities found in screenings (diagnostic) or for high-risk screening without abnormalities (supplemental), based on medical guidelines. Plans can still require prior authorization for these exams, and state laws offering stronger protections remain in effect. The rule takes effect for plan years starting January 1, 2026.
HR 3045, the West Bank Violence Prevention Act of 2025, imposes U.S. sanctions on foreign individuals and entities responsible for violence, displacement, or property destruction in the West Bank. It targets those directly involved in attacks on civilians, forced displacement, or property seizures, including settler leaders or officials of groups engaged in such activities. Key provisions require freezing assets of sanctioned individuals within U.S. jurisdiction and blocking their entry into the United States via visa restrictions. The law applies to foreign nationals meeting specific criteria outlined in the bill, not U.S. citizens or entities.
HR 3043 prohibits U.S. federal funding for biomedical research involving vertebrate animals conducted in or by entities located in China (including Hong Kong), Iran, North Korea, or Russia. It directly affects research institutions receiving grants or contracts from the Department of Health and Human Services (HHS) that would conduct such animal testing in those four countries. The bill bans HHS from directly conducting this research or funding it through grants, contracts, or other federal support. It also requires HHS to submit detailed reports to Congress within 60 days when adding new countries to the restricted list, as determined with input from State and Defense departments. This is a funding restriction, not a ban on all international research.
The BUILD Act of 2025 creates two federal grant programs to help small communities improve public safety infrastructure. It provides up to $4 million per project for law enforcement agencies serving communities under 50,000 residents to upgrade facilities focused on emergency services, officer training, recruitment, or community safety. Similarly, it offers grants for fire departments (career, combination, or volunteer) in the same size communities to enhance facilities for firefighting, emergency medical services, personnel training, or community safety. The bill authorizes $250 million annually from 2026 through 2028 for each program and requires annual reports on grant usage and infrastructure needs.
